Back to Search
HOWARD HOCHSTER, MD
MD
Internal Medicine Physician
NPI: 1497768808IndividualAccepts Medicare
Specialties, Licenses & Credentials
Internal Medicine PhysicianPrimary
Internal Medicine
Code: 207R00000X
217550(NY)
CMS Specialties
PrimaryINTERNAL MEDICINE
Education
ALBERT EINSTEIN COLLEGE OF MEDICINE OF YESHIVA UNIVERSITY
Class of 1998
Clinical Trials (1)
1
Linked Trials
1
Recruiting
0
With Results
Research & Publications (20)
Maintenance rituximab after cyclophosphamide, vincristine, and prednisone prolongs progression-free survival in advanced indolent lymphoma: results of the randomized phase III ECOG1496 Study.
PMID 19255334·J Clin Oncol·2009
3-trial
Safety and efficacy of oxaliplatin and fluoropyrimidine regimens with or without bevacizumab as first-line treatment of metastatic colorectal cancer: results of the TREE Study.
PMID 18640933·J Clin Oncol·2008
4-observational
Tolerance and activity of oxaliplatin with protracted topotecan infusion in patients with previously treated ovarian cancer. A phase I study.
PMID 18191187·Gynecol Oncol·2008
3-trial
The power of "p": on overpowered clinical trials and "positive" results.
PMID 19259305·Gastrointest Cancer Res·2008
8-other
Phase II study of uracil-tegafur with leucovorin in elderly (> or = 75 years old) patients with colorectal cancer: ECOG 1299.
PMID 18048821·J Clin Oncol·2007
3-trial
Bevacizumab in combination with chemotherapy: first-line treatment of patients with metastatic colorectal cancer.
PMID 17145525·Semin Oncol·2006
6-review
Prolonged topotecan infusion with cisplatin in the first-line treatment of ovarian cancer: an NYGOG and ECOG study.
PMID 16253316·Gynecol Oncol·2006
3-trial
Capecitabine plus oxaliplatin vs infusional 5-fluorouracil plus oxaliplatin in the treatment of colorectal cancer. Con: Pumpin' FU (or, avoiding that oral fixation).
PMID 16167014·Clin Adv Hematol Oncol·2005
8-other
Phase I/II dose-escalation study of pemetrexed plus irinotecan in patients with advanced colorectal cancer.
PMID 16356302·Clin Colorectal Cancer·2005
3-trial
The role of pemetrexed in the treatment of gastrointestinal malignancy.
PMID 15377402·Clin Colorectal Cancer·2004
6-review
Biweekly 72-hour 9-aminocamptothecin infusion as second-line therapy for ovarian carcinoma: phase II study of the New York Gynecologic Oncology Group and the Eastern Cooperative Oncology Group.
PMID 14701774·J Clin Oncol·2004
3-trial
Newer approaches to gemcitabine-based therapy of pancreatic cancer: fixed-dose-rate infusion and novel agents.
PMID 12826248·Int J Radiat Oncol Biol Phys·2003
6-review
Oxaliplatin with weekly bolus fluorouracil and low-dose leucovorin as first-line therapy for patients with colorectal cancer.
PMID 12860947·J Clin Oncol·2003
3-trial
Opportunities for newer agents in combination with oxaliplatin.
PMID 14523797·Semin Oncol·2003
6-review
Activity and safety of vinorelbine combined with doxorubicin or fluorouracil as first-line therapy in advanced breast cancer: a stratified phase II study.
PMID 11423674·Oncologist·2001
3-trial
Phase I study of fludarabine plus cyclophosphamide in patients with previously untreated low-grade lymphoma: results and and long-term follow-up--a report from the Eastern Cooperative Oncology Group.
PMID 10694548·J Clin Oncol·2000
3-trial
Phase II study of darinaparsin in patients with advanced hepatocellular carcinoma.
PMID 19565187·Invest New Drugs·2010
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 2233 ESPLANADE AVE
BRONX, NY 10469 - Phone
- (718) 918-1100
Quick Facts
- NPI
- 1497768808
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 28
- Clinical Trials
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile